FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What CMC Questions Did They Answer? (Part 2) By Richard A. Lewis, Senior Regulatory Device & Biologics Expert & James E. Valentine —

https://www.thefdalawblog.com/2024/12/fda-issues-cliffs-notes-style-guidance-on-cell-and-gene-therapy-what-cmc-questions-did-they-answer-part-2/?utm_source=rss&utm_medium=rss&utm_campaign=fda-issues-cliffs-notes-style-guidance-on-cell-and-gene-therapy-what-cmc-questions-did-they-answer-part-2